meglumine has been researched along with End Stage Liver Disease in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cai, S; Lin, N; Lin, X; Ma, W; Wang, X; Wang, Y; Yang, Y; Zhao, X | 1 |
1 other study(ies) available for meglumine and End Stage Liver Disease
| Article | Year |
|---|---|
The value of contrast-enhanced portal vein imaging at the hepatobiliary phase obtained with gadobenate dimeglumine for predicting decompensation and transplant-free survival in chronic liver disease.
Topics: Contrast Media; End Stage Liver Disease; Gadolinium DTPA; Humans; Liver Cirrhosis; Liver Diseases; Magnetic Resonance Imaging; Meglumine; Organometallic Compounds; Portal Vein; Retrospective Studies; Severity of Illness Index | 2023 |